Cabermax 1mg

Active Ingredient Cabergoline
Treatment High levels of prolactin
Manufacturer John Lee
Packaging 4 Tablets in Strip
Strength 1mg

This product is currently out of stock and unavailable.

SKU: Cabermax 1 Category: Tag:

Description

Cabermax 1mg is a medicine most recognized for its primary component, cabergoline, which is often used to treat diseases caused by high levels of the hormone prolactin. Cabermax 1mg, which is manufactured for its efficacy and convenience of use, received medical attention for its role in the treatment of hyperprolactinemia, Parkinson’s disease, and other disorders.

What is Cabermax 1mg?

Cabermax 1mg is a dopaminergic drug that activates dopamine receptors. Dopamine is a neurotransmitter that regulates mood, locomotion, and hormone production. Cabermax works by activating dopamine receptors to reduce prolactin levels in the blood, which helps to treat hyperprolactinemia disorders.

Uses of Cabermax 1mg

Treatment of Hyperprolactinemia

Hyperprolactinemia is a condition defined by unusually high prolactin levels in the bloodstream. This hormone, generated by the pituitary gland, stimulates milk production after delivery. But high prolactin levels may induce a variety of symptoms, including infertility, irregular menstruation periods in women, and low testosterone levels in males. Cabermax 1mg is effective in lowering prolactin levels, which relieves these symptoms.

Parkinson’s Disease

Parkinson’s disease is a degenerative neurological illness that affects movement. Cabermax 1mg has been shown to help treat Parkinson’s disease owing to its dopamine agonist characteristics. Cabermax, which stimulates dopamine receptors, can help increase motor function and reduce symptoms including tremors, stiffness, and bradykinesia.

Other Uses

Cabermax 1mg is used on occasion to treat disorders other than hyperprolactinemia and Parkinson’s disease, including:

  • Restless Legs Syndrome (RLS)
  • Cushing’s Disease
  • Prolactinomas (prolactin-secreting tumors)

How to Take Cabermax 1mg

Dosage and Administration

Cabermax 1mg is typically used orally, with or without meals. The dose and length of therapy are determined by the medical condition being treated and the patient’s reaction to the medicine. It is important to carefully follow the directions provided by the prescribing physician. Typically, the therapy begins with a small dosage that can be progressively raised to reduce side effects.

Missed Dose

If a dosage is missed, take it as soon as possible, unless it is nearly time for the next dose. In such instances, skip the missing dosage and return to your usual dosing regimen. Do not increase the dosage to catch up.

Side Effects of Cabermax 1mg

Cabermax 1mg, like other medicines, can result in side effects. While not everyone experiences them, it is important to be aware of possible negative consequences.

Common Side Effects

  • Nausea
  • Vomiting
  • Headache
  • Dizziness
  • Fatigue

Serious Side Effects

  • Hypotension (low blood pressure)
  • Psychiatric symptoms such as hallucinations or confusion
  • Cardiac issues like heart valve problems
  • Pulmonary fibrosis (scarring of lung tissue)

Precautions and Warnings

Medical History

Before using Cabermax 1mg, it is important to tell your doctor of any medical history, particularly:

  • Heart disease
  • Lung problems
  • Liver disease
  • Psychiatric disorders

Pregnancy and Breastfeeding

Cabermax 1mg should be taken during pregnancy only when confirmed and recommended by a doctor. It is not suggested for usage during nursing since it can decrease milk production.

Interactions with Other Medications

Cabermax 1mg can react with other drugs, impacting their effects. Inform the doctor or your practitioner about any prescription and non-prescription medications, including herbal supplements. Some significant interactions include:

  • Antipsychotic medications
  • Blood pressure medications
  • Other dopamine agonists

Reviews

There are no reviews yet.

Be the first to review “Cabermax 1mg”

Your email address will not be published. Required fields are marked *